Cheng Hsia
Direktor/Vorstandsmitglied bei TANVEX BIOPHARMA, INC.
Profil
Cheng Hsia is a professional who currently works as a Director at Tanvex BioPharma, Inc. He previously worked as a Director at Tanvex BioPharma USA, Inc. and as a Manager-Pharmaceutical Technology at Baxter International, Inc. Prior to that, he worked at Actavis, Inc. for 24 years, where he held the position of Senior Vice President-Research & Development from 1990 to 2008.
Dr. Hsia holds a doctorate degree from Purdue University.
Aktive Positionen von Cheng Hsia
| Unternehmen | Position | Beginn |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 15.05.2015 |
Ehemalige bekannte Positionen von Cheng Hsia
| Unternehmen | Position | Ende |
|---|---|---|
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
| BAXTER INTERNATIONAL INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| Tanvex BioPharma USA, Inc. | Direktor/Vorstandsmitglied | - |
Ausbildung von Cheng Hsia
| Purdue University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| TANVEX BIOPHARMA, INC. | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Tanvex BioPharma USA, Inc. | |
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Actavis, Inc. is a pharmaceutical company. It focuses on the development and distribution of generic products. The company engages in developing, manufacturing and marketing generic, branded generic, legacy brands and over-the-counter products. It operates its business in three segments: Actavis Pharma, Actavis Specialty Brands and Distribution. The Actavis Pharma segment develops and out-licenses generic pharmaceutical products outside the U.S. through its medis third-party business. The Actavis Specialty Brands segment engages in developing and marketing biosimilars products in women's health, oncology and other therapeutic categories. The Distribution segment distributes generic, select brand pharmaceutical products, vaccines, injectables and over-the-counter medicines from suppliers to independent pharmacies, alternate care providers, pharmacy chains and physicians offices. The company was founded by Allen Y. Chao and David C. Hsia in 1984 and is headquartered in Parsippany, NJ. | Health Technology |
